Literature DB >> 31856074

Cascade of Provider-Initiated Human Immunodeficiency Virus Testing and Counselling at Specific Life Events (Pregnancy, Sexually Transmitted Infections, Marriage) in Côte d'Ivoire.

Maxime Inghels1, Arsène Kra Kouassi2, Serge Niangoran2, Anne Bekelynck1,2, Séverine Carillon1, Lazare Sika3, Christine Danel2,4, Mariatou Kone5, Annabel Desgrées du Loû1, Joseph Larmarange1.   

Abstract

BACKGROUND: Despite the implementation of Provider Initiated Testing and Counselling (PITC) in 2009, PITC coverage remains low in Cote d'Ivoire. The purpose of this study is to determine whether an human immunodeficiency virus (HIV) test was offered and performed at specific life events where PITC is recommended by national guidelines.
METHODS: In 2017, a cross-sectional telephone survey was conducted among a representative sample of 3,867 adults from the general population in Côte d'Ivoire. The occurrences of the following events over the past 5 years were documented: pregnancy (event A) or partner's pregnancy (event B) of the last child, sexually transmitted infection (event C) and marriage (event D). For each of these events, participants were asked (i) if they consulted a health care professional, (ii) if they were offered an HIV test during that consultation and (iii) if they accepted it.
RESULTS: Consulting a health care provider was reported by 94.9%, 58.3%, 70.3% and 19.1% of those who reported events A, B, C and D respectively. In case of medical consultations following events A, B, C and D, respectively 70.1%, 33.1%, 28.1%, and 78.8% of individuals were offered an HIV test. The testing acceptance was high regardless of the event. Overall, testing coverage was 63.7%, 16.9%, 13.4% and 14.5% for events A, B, C and D respectively.
CONCLUSIONS: Increasing HIV testing coverage in Côte d'Ivoire requires (i) facilitating attendance to health services in case of sexually transmitted infections, marriage and pregnancy-for men-and (ii) strengthening routine testing offer on these occasions.

Entities:  

Mesh:

Year:  2020        PMID: 31856074     DOI: 10.1097/OLQ.0000000000001084

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  4 in total

1.  Telephone peer recruitment and interviewing during a respondent-driven sampling (RDS) survey: feasibility and field experience from the first phone-based RDS survey among men who have sex with men in Côte d'Ivoire.

Authors:  Maxime Inghels; Arsène Kra Kouassi; Serge Niangoran; Anne Bekelynck; Séverine Carillon; Lazare Sika; Mariatou Koné; Christine Danel; Annabel Desgrées du Loû; Joseph Larmarange
Journal:  BMC Med Res Methodol       Date:  2021-02-05       Impact factor: 4.615

2.  Challenges of HIV Self-Test Distribution for Index Testing When HIV Status Disclosure Is Low: Preliminary Results of a Qualitative Study in Bamako (Mali) as Part of the ATLAS Project.

Authors:  Sokhna Boye; Seydou Bouaré; Odette Ky-Zerbo; Nicolas Rouveau; Arlette Simo Fotso; Marc d'Elbée; Romain Silhol; Mathieu Maheu-Giroux; Anthony Vautier; Guillaume Breton; Abdelaye Keita; Anne Bekelynck; Alice Desclaux; Joseph Larmarange; Dolorès Pourette
Journal:  Front Public Health       Date:  2021-05-19

3.  Covariates and Spatial Interpolation of HIV Screening in Mozambique: Insight from the 2015 AIDS Indicator Survey.

Authors:  Pascal Agbadi; Jerry John Nutor; Ernest Darkwah; Henry Ofori Duah; Precious Adade Duodu; Robert Kaba Alhassan; Kimberly Baltzell
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

4.  Describing, analysing and understanding the effects of the introduction of HIV self-testing in West Africa through the ATLAS programme in Côte d'Ivoire, Mali and Senegal.

Authors:  Nicolas Rouveau; Odette Ky-Zerbo; Sokhna Boye; Arlette Simo Fotso; Marc d'Elbée; Mathieu Maheu-Giroux; Romain Silhol; Arsène Kra Kouassi; Anthony Vautier; Clémence Doumenc-Aïdara; Guillaume Breton; Abdelaye Keita; Eboi Ehui; Cheikh Tidiane Ndour; Marie-Claude Boilly; Fern Terris-Prestholt; Dolorès Pourette; Alice Desclaux; Joseph Larmarange
Journal:  BMC Public Health       Date:  2021-01-21       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.